Erratum: Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL (Blood Advances (2017) 1:14 (933-946) DOI: 10.1182/bloodadvances.2016004176)

Kallesh D. Jayappa; Craig A. Portell; Vicki L. Gordon; Brian J. Capaldo; Stefan Bekiranov; Mark J. Axelrod; L. Kyle Brett; Julia D. Wulfkuhle; Rosa I. Gallagher; Emanuel F. Petricoin; Timothy P. Bender; Michael E. Williams; Michael J. Weber

doi:10.1182/bloodadvances.2017011148

Erratum: Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL (Blood Advances (2017) 1:14 (933-946) DOI: 10.1182/bloodadvances.2016004176)

Kallesh D. Jayappa, Craig A. Portell, Vicki L. Gordon, Brian J. Capaldo, Stefan Bekiranov, Mark J. Axelrod, L. Kyle Brett, Julia D. Wulfkuhle, Rosa I. Gallagher, Emanuel F. Petricoin, Timothy P. Bender, Michael E. Williams, Michael J. Weber

Research output: Contribution to journal › Comment/debate

Abstract

On page 933 of the 13 June 2017 issue, the affiliation of author Mark J. Axelrod was incorrect. The corrected author list and affiliation line are shown below. The error has been corrected in the published article.

Original language	English
Pages (from-to)	1537
Number of pages	1
Journal	Blood Advances
Volume	1
Issue number	19
DOIs	https://doi.org/10.1182/bloodadvances.2017011148
State	Published - 22 Aug 2017
Externally published	Yes

Access to Document

10.1182/bloodadvances.2017011148

Fingerprint

Dive into the research topics of 'Erratum: Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL (Blood Advances (2017) 1:14 (933-946) DOI: 10.1182/bloodadvances.2016004176)'. Together they form a unique fingerprint.

Cite this

Jayappa, K. D., Portell, C. A., Gordon, V. L., Capaldo, B. J., Bekiranov, S., Axelrod, M. J., Kyle Brett, L., Wulfkuhle, J. D., Gallagher, R. I., Petricoin, E. F., Bender, T. P., Williams, M. E., & Weber, M. J. (2017). Erratum: Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL (Blood Advances (2017) 1:14 (933-946) DOI: 10.1182/bloodadvances.2016004176). Blood Advances, 1(19), 1537. https://doi.org/10.1182/bloodadvances.2017011148

@article{554b4e7b5e9c426e95af5b5438e049bc,

title = "Erratum: Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL (Blood Advances (2017) 1:14 (933-946) DOI: 10.1182/bloodadvances.2016004176)",

abstract = "On page 933 of the 13 June 2017 issue, the affiliation of author Mark J. Axelrod was incorrect. The corrected author list and affiliation line are shown below. The error has been corrected in the published article.",

author = "Jayappa, {Kallesh D.} and Portell, {Craig A.} and Gordon, {Vicki L.} and Capaldo, {Brian J.} and Stefan Bekiranov and Axelrod, {Mark J.} and {Kyle Brett}, L. and Wulfkuhle, {Julia D.} and Gallagher, {Rosa I.} and Petricoin, {Emanuel F.} and Bender, {Timothy P.} and Williams, {Michael E.} and Weber, {Michael J.}",

year = "2017",

month = aug,

day = "22",

doi = "10.1182/bloodadvances.2017011148",

language = "English",

volume = "1",

pages = "1537",

journal = "Blood Advances",

issn = "2473-9529",

number = "19",

}

Jayappa, KD, Portell, CA, Gordon, VL, Capaldo, BJ, Bekiranov, S, Axelrod, MJ, Kyle Brett, L, Wulfkuhle, JD, Gallagher, RI, Petricoin, EF, Bender, TP, Williams, ME & Weber, MJ 2017, 'Erratum: Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL (Blood Advances (2017) 1:14 (933-946) DOI: 10.1182/bloodadvances.2016004176)', Blood Advances, vol. 1, no. 19, pp. 1537. https://doi.org/10.1182/bloodadvances.2017011148

Erratum: Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL (Blood Advances (2017) 1:14 (933-946) DOI: 10.1182/bloodadvances.2016004176). / Jayappa, Kallesh D.; Portell, Craig A.; Gordon, Vicki L. et al.
In: Blood Advances, Vol. 1, No. 19, 22.08.2017, p. 1537.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL (Blood Advances (2017) 1:14 (933-946) DOI: 10.1182/bloodadvances.2016004176)

AU - Jayappa, Kallesh D.

AU - Portell, Craig A.

AU - Gordon, Vicki L.

AU - Capaldo, Brian J.

AU - Bekiranov, Stefan

AU - Axelrod, Mark J.

AU - Kyle Brett, L.

AU - Wulfkuhle, Julia D.

AU - Gallagher, Rosa I.

AU - Petricoin, Emanuel F.

AU - Bender, Timothy P.

AU - Williams, Michael E.

AU - Weber, Michael J.

PY - 2017/8/22

Y1 - 2017/8/22

N2 - On page 933 of the 13 June 2017 issue, the affiliation of author Mark J. Axelrod was incorrect. The corrected author list and affiliation line are shown below. The error has been corrected in the published article.

AB - On page 933 of the 13 June 2017 issue, the affiliation of author Mark J. Axelrod was incorrect. The corrected author list and affiliation line are shown below. The error has been corrected in the published article.

UR - http://www.scopus.com/inward/record.url?scp=85073258786&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2017011148

DO - 10.1182/bloodadvances.2017011148

M3 - Comment/debate

AN - SCOPUS:85073258786

SN - 2473-9529

VL - 1

SP - 1537

JO - Blood Advances

JF - Blood Advances

IS - 19

ER -